ATE306941T1 - Gesteigerte abgabe von auf nukleinsäuren basierenden arzneimitteln - Google Patents

Gesteigerte abgabe von auf nukleinsäuren basierenden arzneimitteln

Info

Publication number
ATE306941T1
ATE306941T1 AT00927515T AT00927515T ATE306941T1 AT E306941 T1 ATE306941 T1 AT E306941T1 AT 00927515 T AT00927515 T AT 00927515T AT 00927515 T AT00927515 T AT 00927515T AT E306941 T1 ATE306941 T1 AT E306941T1
Authority
AT
Austria
Prior art keywords
nucleic acid
medicinal products
increased delivery
based medicinal
based drug
Prior art date
Application number
AT00927515T
Other languages
English (en)
Inventor
Michela Seveso
Daniel J O'mahony
David T Page
Original Assignee
Merrion Res I Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrion Res I Ltd filed Critical Merrion Res I Ltd
Application granted granted Critical
Publication of ATE306941T1 publication Critical patent/ATE306941T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00927515T 1999-05-05 2000-05-05 Gesteigerte abgabe von auf nukleinsäuren basierenden arzneimitteln ATE306941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13260399P 1999-05-05 1999-05-05
PCT/GB2000/001726 WO2000067798A2 (en) 1999-05-05 2000-05-05 Enhanced delivery of nucleic acid-based drugs

Publications (1)

Publication Number Publication Date
ATE306941T1 true ATE306941T1 (de) 2005-11-15

Family

ID=22454795

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00927515T ATE306941T1 (de) 1999-05-05 2000-05-05 Gesteigerte abgabe von auf nukleinsäuren basierenden arzneimitteln

Country Status (7)

Country Link
EP (1) EP1173217B1 (de)
JP (1) JP2002544175A (de)
AT (1) ATE306941T1 (de)
AU (1) AU4591200A (de)
CA (1) CA2371095A1 (de)
DE (1) DE60023285D1 (de)
WO (1) WO2000067798A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MY150740A (en) 2002-10-24 2014-02-28 Abbvie Biotechnology Ltd Low dose methods for treating disorders in which tnf? activity is detrimental
WO2023209437A1 (en) 2022-04-29 2023-11-02 Haya Therapeutics Sa Compositions and methods of modulating long noncoding transcripts associated with ards induced pulmonary fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739118A (en) * 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
ATE321882T1 (de) * 1997-07-01 2006-04-15 Isis Pharmaceuticals Inc Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
CA2242035C (en) * 1997-07-01 2004-11-23 Transgene S.A. Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy
JP2002515514A (ja) * 1998-05-21 2002-05-28 アイシス・ファーマシューティカルス・インコーポレーテッド オリゴヌクレオチドの局所送逹のための組成物及び方法
AU5093199A (en) * 1998-07-08 2000-02-01 Oryxe Transdermal delivery system

Also Published As

Publication number Publication date
AU4591200A (en) 2000-11-21
WO2000067798A2 (en) 2000-11-16
JP2002544175A (ja) 2002-12-24
EP1173217A2 (de) 2002-01-23
CA2371095A1 (en) 2000-11-16
WO2000067798A3 (en) 2001-02-08
EP1173217B1 (de) 2005-10-19
DE60023285D1 (de) 2006-03-02

Similar Documents

Publication Publication Date Title
NO20022058D0 (no) Farmasöytiske sammensetninger
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
HK1097449A1 (en) Methods for in vivo delivery of biologics and compositions useful therefor
SE0300010D0 (sv) Novel Compounds
SE0003449D0 (sv) Anticancer compositions
HUP0003323A2 (hu) Vorikonazolt tartalmazó gyógyászati készítmények
ATE426635T1 (de) Arzneimittelverabreichung
ATE356612T1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
CY1106137T1 (el) Φαρμακευτικη συνθεση πepιλαμβανουσα λουμιρακοξιμπη
ATE292453T1 (de) Antivirale arznei
CY1105795T1 (el) Σκευασματα για βελτιωση της βιοδιαθεσιμοτητας χορηγουμενων απο το στομα φαρμακων
SI1383752T1 (sl) Devterirani 3-piperidinopropiofenoni in zdravila, ki vsebujejo te spojine
ITMI921831A1 (it) Composizioni farmaceutiche in forma di microemulsioni o di dispersioni liposomiali bioadesive per la somministrazione transmucosale di sostanze peptidiche e di proteine farmacologicamente attive
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
EP1279406A4 (de) Transporters und arzneimittelabgabesysteme die diese verwenden
WO2001047913A3 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
ATE289801T1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
WO2003032946A3 (en) Ph-sensitive liposomes for targeted drug delivery
ATE230258T1 (de) Injizierbares arzneimittel auf basis eines pharmazeutisch verträglichen salzes von clopidogrel bzw. von ticlopidin
ATE306941T1 (de) Gesteigerte abgabe von auf nukleinsäuren basierenden arzneimitteln
WO2000048445A3 (de) Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit
BRPI0510855A (pt) medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.
FR2811576B1 (fr) Disposits ou appareils d'administration de produits actifs pulverurents du type medicaments ou vaccins, par voie pulmonaire

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties